Royal Bank of Canada’s Intellipharmaceuticals International Inc. IPCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,446
| Closed | – | – | 7340 |
|
|
2018
Q4 | $0 | Buy |
2,446
+135
| +6% | +$83 | ﹤0.01% | 7454 |
|
|
2018
Q3 | $6K | Buy |
2,311
+666
| +40% | +$2.23K | ﹤0.01% | 6230 |
|
|
2018
Q2 | $7K | Buy |
1,645
+56
| +4% | +$254 | ﹤0.01% | 5964 |
|
|
2018
Q1 | $9K | Sell |
1,589
-32
| -2% | -$231 | ﹤0.01% | 5777 |
|
|
2017
Q4 | $13K | Buy |
1,621
+1,620
| +162,000% | +$14.7K | ﹤0.01% | 5779 |
|
|
2017
Q3 | $0 | Sell |
1
-59
| -98% | -$842 | ﹤0.01% | 7186 |
|
|
2017
Q2 | $1K | Sell |
60
-11
| -15% | -$231 | ﹤0.01% | 6492 |
|
|
2017
Q1 | $1K | Buy |
71
+11
| +18% | +$284 | ﹤0.01% | 6544 |
|
|
2016
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 6509 |
|
|
2016
Q3 | $1K | Sell |
60
-4,550
| -99% | -$81.6K | ﹤0.01% | 6342 |
|
|
2016
Q2 | $72K | Buy |
4,610
+4,550
| +7,583% | +$82.9K | ﹤0.01% | 4935 |
|
|
2016
Q1 | $1K | Sell |
60
-30
| -33% | -$667 | ﹤0.01% | 6268 |
|
|
2015
Q4 | $2K | Sell |
90
-1
| -1% | -$19 | ﹤0.01% | 6407 |
|
|
2015
Q3 | $2K | Buy |
91
+60
| +194% | +$1.58K | ﹤0.01% | 6417 |
|
|
2015
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 6502 |
|
|
2015
Q1 | $1K | Buy |
31
+1
| +3% | +$24 | ﹤0.01% | 6023 |
|
|
2014
Q4 | $1K | Buy |
+30
| New | +$811 | ﹤0.01% | 6081 |
|
|
2014
Q3 | – | Sell |
-7
| Closed | -$202 | – | 6231 |
|
|
2014
Q2 | $0 | Buy |
+7
| New | +$270 | ﹤0.01% | 6256 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6261 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6283 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6348 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5873 |
|
Royal Bank of Canada's IPCI Position: Q1 2019 in Review
Royal Bank of Canada sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 2,446 shares.
Royal Bank of Canada first reported a position in IPCI in Q2 2014 and held it in 18 quarters. The position peaked at $72K in Q2 2016. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.
- Royal Bank of Canada reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
- Royal Bank of Canada sold 2,446 Intellipharmaceuticals International Inc. shares in Q1 2019.
- Royal Bank of Canada first reported a position in Intellipharmaceuticals International Inc. in Q2 2014 and held it in 18 quarters.
- Royal Bank of Canada's Intellipharmaceuticals International Inc. position peaked at $72K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.
Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.